nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—ACTN2—dilated cardiomyopathy	0.0513	0.105	CbGpPWpGaD
Butabarbital—Ataxia—Spironolactone—dilated cardiomyopathy	0.0367	0.0717	CcSEcCtD
Butabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—ACTN2—dilated cardiomyopathy	0.0254	0.0519	CbGpPWpGaD
Butabarbital—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.0225	0.0439	CcSEcCtD
Butabarbital—Confusional state—Spironolactone—dilated cardiomyopathy	0.0193	0.0378	CcSEcCtD
Butabarbital—Somnolence—Spironolactone—dilated cardiomyopathy	0.017	0.0333	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0168	0.0343	CbGpPWpGaD
Butabarbital—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0158	0.0309	CcSEcCtD
Butabarbital—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0151	0.0296	CcSEcCtD
Butabarbital—Ataxia—Lisinopril—dilated cardiomyopathy	0.015	0.0293	CcSEcCtD
Butabarbital—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0141	0.0276	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0137	0.028	CbGpPWpGaD
Butabarbital—Dizziness—Spironolactone—dilated cardiomyopathy	0.0127	0.0248	CcSEcCtD
Butabarbital—GRIA2—N-cadherin signaling events—GJA1—dilated cardiomyopathy	0.0127	0.0259	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0124	0.0254	CbGpPWpGaD
Butabarbital—Vomiting—Spironolactone—dilated cardiomyopathy	0.0122	0.0238	CcSEcCtD
Butabarbital—Rash—Spironolactone—dilated cardiomyopathy	0.0121	0.0236	CcSEcCtD
Butabarbital—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0121	0.0236	CcSEcCtD
Butabarbital—Headache—Spironolactone—dilated cardiomyopathy	0.012	0.0235	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0119	0.0244	CbGpPWpGaD
Butabarbital—Agitation—Furosemide—dilated cardiomyopathy	0.0117	0.0229	CcSEcCtD
Butabarbital—Nausea—Spironolactone—dilated cardiomyopathy	0.0114	0.0223	CcSEcCtD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0113	0.0231	CbGpPWpGaD
Butabarbital—Bradycardia—Lisinopril—dilated cardiomyopathy	0.0112	0.0219	CcSEcCtD
Butabarbital—Hallucination—Lisinopril—dilated cardiomyopathy	0.011	0.0214	CcSEcCtD
Butabarbital—Confusional state—Furosemide—dilated cardiomyopathy	0.0105	0.0206	CcSEcCtD
Butabarbital—Shock—Furosemide—dilated cardiomyopathy	0.0103	0.0201	CcSEcCtD
Butabarbital—Hypotension—Furosemide—dilated cardiomyopathy	0.00974	0.019	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00974	0.0199	CbGpPWpGaD
Butabarbital—GRIA2—N-cadherin signaling events—RAC1—dilated cardiomyopathy	0.00965	0.0198	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00949	0.0194	CbGpPWpGaD
Butabarbital—Tension—Lisinopril—dilated cardiomyopathy	0.0094	0.0184	CcSEcCtD
Butabarbital—GRIK2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00933	0.0191	CbGpPWpGaD
Butabarbital—Nervousness—Lisinopril—dilated cardiomyopathy	0.00931	0.0182	CcSEcCtD
Butabarbital—Somnolence—Furosemide—dilated cardiomyopathy	0.00927	0.0181	CcSEcCtD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00921	0.0188	CbGpPWpGaD
Butabarbital—Constipation—Furosemide—dilated cardiomyopathy	0.00891	0.0174	CcSEcCtD
Butabarbital—Angioedema—Lisinopril—dilated cardiomyopathy	0.00876	0.0171	CcSEcCtD
Butabarbital—Syncope—Lisinopril—dilated cardiomyopathy	0.00859	0.0168	CcSEcCtD
Butabarbital—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00859	0.0168	CcSEcCtD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00849	0.0174	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00846	0.0173	CbGpPWpGaD
Butabarbital—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00842	0.0165	CcSEcCtD
Butabarbital—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00824	0.0161	CcSEcCtD
Butabarbital—Anxiety—Lisinopril—dilated cardiomyopathy	0.00813	0.0159	CcSEcCtD
Butabarbital—Confusional state—Lisinopril—dilated cardiomyopathy	0.00789	0.0154	CcSEcCtD
Butabarbital—Shock—Lisinopril—dilated cardiomyopathy	0.00769	0.015	CcSEcCtD
Butabarbital—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00768	0.015	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00746	0.0153	CbGpPWpGaD
Butabarbital—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00732	0.015	CbGpPWpGaD
Butabarbital—Hypotension—Lisinopril—dilated cardiomyopathy	0.00731	0.0143	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00715	0.0146	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00714	0.0146	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00713	0.0146	CbGpPWpGaD
Butabarbital—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.00712	0.0146	CbGpPWpGaD
Butabarbital—Somnolence—Lisinopril—dilated cardiomyopathy	0.00695	0.0136	CcSEcCtD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00692	0.0142	CbGpPWpGaD
Butabarbital—Dizziness—Furosemide—dilated cardiomyopathy	0.00689	0.0135	CcSEcCtD
Butabarbital—CHRNA7—Neuronal System—ABCC9—dilated cardiomyopathy	0.00678	0.0139	CbGpPWpGaD
Butabarbital—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00669	0.0137	CbGpPWpGaD
Butabarbital—Constipation—Lisinopril—dilated cardiomyopathy	0.00669	0.0131	CcSEcCtD
Butabarbital—Vomiting—Furosemide—dilated cardiomyopathy	0.00663	0.013	CcSEcCtD
Butabarbital—Rash—Furosemide—dilated cardiomyopathy	0.00657	0.0129	CcSEcCtD
Butabarbital—Dermatitis—Furosemide—dilated cardiomyopathy	0.00657	0.0128	CcSEcCtD
Butabarbital—Headache—Furosemide—dilated cardiomyopathy	0.00653	0.0128	CcSEcCtD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00652	0.0133	CbGpPWpGaD
Butabarbital—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.00651	0.0133	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—ACTN2—dilated cardiomyopathy	0.0065	0.0133	CbGpPWpGaD
Butabarbital—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00645	0.0126	CcSEcCtD
Butabarbital—Nausea—Furosemide—dilated cardiomyopathy	0.00619	0.0121	CcSEcCtD
Butabarbital—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00618	0.0121	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00603	0.0123	CbGpPWpGaD
Butabarbital—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00585	0.012	CbGpPWpGaD
Butabarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—dilated cardiomyopathy	0.00577	0.0118	CbGpPWpGaD
Butabarbital—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00576	0.0113	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.0057	0.0117	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0057	0.0117	CbGpPWpGaD
Butabarbital—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00569	0.0116	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00553	0.0113	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00547	0.0112	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00536	0.011	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.0053	0.0109	CbGpPWpGaD
Butabarbital—Dizziness—Lisinopril—dilated cardiomyopathy	0.00517	0.0101	CcSEcCtD
Butabarbital—Vomiting—Lisinopril—dilated cardiomyopathy	0.00497	0.00972	CcSEcCtD
Butabarbital—Rash—Lisinopril—dilated cardiomyopathy	0.00493	0.00964	CcSEcCtD
Butabarbital—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00493	0.00963	CcSEcCtD
Butabarbital—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0049	0.01	CbGpPWpGaD
Butabarbital—Headache—Lisinopril—dilated cardiomyopathy	0.0049	0.00958	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00466	0.00954	CbGpPWpGaD
Butabarbital—Nausea—Lisinopril—dilated cardiomyopathy	0.00465	0.00908	CcSEcCtD
Butabarbital—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00428	0.00877	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00428	0.00877	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00411	0.0084	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00404	0.00828	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00392	0.00802	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.0038	0.00778	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00376	0.00769	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00352	0.00721	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00342	0.00701	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.0033	0.00675	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00328	0.00672	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00318	0.00652	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00282	0.00578	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00257	0.00526	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00255	0.00521	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00248	0.00507	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00248	0.00507	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00235	0.00482	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00233	0.00477	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0023	0.00471	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00227	0.00464	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00227	0.00464	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00216	0.00442	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00212	0.00435	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00211	0.00432	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00211	0.00431	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00209	0.00429	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00204	0.00418	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00204	0.00417	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00198	0.00405	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00198	0.00405	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00193	0.00395	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00184	0.00377	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—RAF1—dilated cardiomyopathy	0.00163	0.00333	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00162	0.00332	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00162	0.00332	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00157	0.00322	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00154	0.00315	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00148	0.00304	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—RAF1—dilated cardiomyopathy	0.00148	0.00303	CbGpPWpGaD
Butabarbital—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00144	0.00295	CbGpPWpGaD
Butabarbital—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00132	0.0027	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.0013	0.00265	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00125	0.00257	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—RAF1—dilated cardiomyopathy	0.00124	0.00255	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00122	0.0025	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—RAF1—dilated cardiomyopathy	0.00121	0.00247	CbGpPWpGaD
Butabarbital—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00115	0.00236	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00112	0.00228	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000975	0.002	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000934	0.00191	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000854	0.00175	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000777	0.00159	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000747	0.00153	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000502	0.00103	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000459	0.00094	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000402	0.000822	CbGpPWpGaD
